Modality.AI, Inc. has developed the first automated, clinically validated, multimodal system to assess neurological and psychiatric states, in clinic and remotely.
Modality's conversational AI system monitors neurological and psychiatric conditions: frequently, automatically, accurately, consistently. Researchers and clinicians can now review data in near real-time and monitor treatment response over time, paving the way for more efficient, effective, and less costly clinical trials.
Modality was founded by a team of world-class AI / Machine Learning experts. We collaborate with clinicians and researchers at world-leading institutions such as UCSF, UT Southwestern Medical Center, Massachusetts General Hospital, Purdue, Charité.
Numerous IRB-approved clinical studies have chosen Modality to assess indications including ALS, Parkinson’s, autism, depression, and schizophrenia. Our pipeline includes Alzheimer's Disease, Laryngectomy, Long Covid, and post-stroke impairment.
As a clinically validated and HIPAA-compliant system, participants can now be monitored safely at home, while speech and facial responses are streamed and analyzed. Modality makes it possible to assess patients and participants objectively without installing any special software or apps. Modality works on computers, tablets, and smartphones - just about any device with a browser, webcam, and microphone.